Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
New words:
al, Appeal, awaiting, Brucon, burn, captioned, Cautionary, cGLP, cited, compliant, conditionally, deadline, drew, embedded, extimate, Fisher, forfeited, founder, Hope, ID, Inline, insolvency, IPR, Jeffrey, Judge, Magistrate, mix, NaN, NC, opposition, OTCBB, payroll, Petition, prepayment, PTAB, reply, RSU, sharply, tendered, trailing, unpaid, unspecified, uphold, wrote, XBRL
Filing tables
Filing exhibits
FENC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-8 (file nos. 333-221091 and 333-232353) and S-3 (file nos. 333-219884 and 333-249775) of Fennec Pharmaceuticals Inc. (the “Company”) of our report dated February 28, 2022, relating to the consolidated financial statements as of December 31, 2021, which appear in the Annual Report on Form 10-K for the year ended December 31, 2021.
/s/ HASKELL & WHITE LLP
HASKELL & WHITE LLP
Irvine, California
February 28, 2022